Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 289

Results For "ENT"

10734 News Found

FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging
Medical Device | June 01, 2026

FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging

The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes


Clariant bags FDA nod for bio-based PVC additives
R&D | June 01, 2026

Clariant bags FDA nod for bio-based PVC additives

Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes


MediElaj raises $100K to set up AI-powered healthcare kiosks in underserved regions
Medical Device | June 01, 2026

MediElaj raises $100K to set up AI-powered healthcare kiosks in underserved regions

The company is building a connected healthcare ecosystem that utilises smart healthcare kiosk and mobile app to deliver at-home, AI-assisted health screenings and non-invasive health measurements


Oval Fertility launches in Hyderabad, introduces Astec Chronos AI-powered IVF tech to India
Healthcare | June 01, 2026

Oval Fertility launches in Hyderabad, introduces Astec Chronos AI-powered IVF tech to India

Aims to bridge transparency gaps in fertility care, with focus on successful patient outcomes, placing healthy live birth outcomes at the centre of treatment journeys


Indoco's formulation plant at Baddi receives EU GMP certification
News | June 01, 2026

Indoco's formulation plant at Baddi receives EU GMP certification

This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive


AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26
News | June 01, 2026

AstraZeneca's India revenue climbs 33% YoY to Rs. 22.76 billion in FY26

While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications


Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India
Digitisation | June 01, 2026

Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India

Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device


National Policy Dialogue adopts landmark 10-point declaration for people with disabilities
Healthcare | June 01, 2026

National Policy Dialogue adopts landmark 10-point declaration for people with disabilities

World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection


Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Opinion | June 01, 2026

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms


Europe Treponema pallidum tests market to grow at 3% CAGR through 2036
Healthcare | June 01, 2026

Europe Treponema pallidum tests market to grow at 3% CAGR through 2036

Increasing syphilis cases, stronger STI surveillance initiatives, and growing emphasis on early diagnosis are expected to support sustained demand